Navigation Links
Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
Date:4/17/2008

quarter with revenues totaling $1.2 billion, an increase of 13 percent, reflecting strong double-digit sales growth across all product categories. Driving this performance was robust growth from several products used for the treatment of hemophilia and immune disorders, including ADVATE [Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method (rAHF-PFM)] and immune globulin intravenous (IGIV), as well as solid growth from other plasma-based therapies, biosurgery products and vaccines.

Medication Delivery sales grew 8 percent in the quarter to $1.1 billion, with strong global sales of intravenous and nutritional therapies, and significant growth in international sales of anesthesia products and injectable drugs. Renal sales increased 6 percent to $558 million.

Baxter's investment in research and development of $190 million increased 19 percent in the first quarter as the company continues to advance its product pipeline across its business portfolio.

"Our strong and improving financial position reflects the continuing momentum in our business," said Robert L. Parkinson, Jr., chairman and chief executive officer. "Our favorable outlook for the full year allows us to continue to accelerate our investments in research and development programs that will improve treatment for patients, expand access to care and enhance the quality of life for people around the world."

Since the beginning of the year, Baxter has achieved a number of commercial, clinical and regulatory milestones, including:

-- U.S. Food and Drug Administration (FDA) approval of ARTISS [Fibrin

Sealant (Human)], the first and only slow-setting fibrin sealant

indicated for use in adhering skin grafts in adult and pediatric burn

patients.

-- The launch of GELFOAM (R) Plus Hemostasis Kit (absorbable gelatin

sponge, USP and human thrombin), which is indicated as a hemostatic

device for surgical procedures when c
'/>"/>

SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
2. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
3. Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year
4. Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products
5. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
6. Baxter Kidney Patient Education Program Celebrates Tenth Anniversary
7. Baxter Receives 510(k) Clearance From FDA For V-Link With VitalShield, New Antimicrobial Intravascular Technology
8. Baxter Announces FDA Approval of GELFOAM(R) Plus Hemostasis Kit
9. Baxter International Fourth Quarter 2007 Financial Results Conference Call
10. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
11. Baxters Costa Rica Facility Recognized With Shingo Prize for Excellence in Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... 15 AstraZeneca (NYSE: ... (UVa) in Charlottesville, today announced that they ... to enhance development of new treatments primarily ... secondary focus on peripheral vascular disease (PAD). ... The collaborative preclinical research projects will focus ...
(Date:12/15/2009)... MANOR, N.Y., Dec. 15 The International ... that the professional society is continuing to accept ... being held in Arlington, VA, April 19-21, 2010. ... is encouraging non-members to join the organization to ... The submission deadline is 12 AM EST, January ...
(Date:12/15/2009)... and LONDON, Dec. 15 ... Thomson Pharma ® has become the first drug ... protocol and outcome information. This highly anticipated new ... customers this month. ,, Thomson ... intelligence from registries, publications, press releases, conferences, and ...
(Date:12/14/2009)... and THOUSAND OAKS, Calif., Dec. 14 ... Amgen Inc.(Nasdaq: AMGN ) today announced that ... worldwide rights to Array,s small-molecule glucokinase activator program, ... 1 clinical trial in patients with Type 2 ... the agreement, Array will receive an upfront payment ...
Breaking Biology Technology:AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 2The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 3Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7
... Claire, Wis. When Suzanne DeCann visits the University ... May, it will be to pick up her newly earned ... Georgia, will be among the first 11 UW-Eau Claire students ... Eau Claire for commencement, shell get her first real look ...
... announced Saturday it will feature its carbon dioxide-cooled Jeep ... Cedar Rapids, Iowa, May 3-5. This vehicle features an ... emissions, cools faster than current systems and is more ... of space under the hood. , ,Carbon dioxide is ...
... NameProtect has announced a new version of its online ... are showing up in search-engine ads. , ,NameProtects search tools ... are not already taken, or that their trademarks are not ... monitors search-engine ads daily and watches for trademarks that other ...
Other Biology Technology:UW-Eau Claire graduates first online MBAs 2UW-Eau Claire graduates first online MBAs 3
(Date:12/15/2009)... December 2009 - Scientists at VIB and Ghent University ... the treatment of septic shock, the major cause of ... of nitric oxide (NO) gas in mice with septic ... the animal,s organs showed much less damage, while their ... expectations, since it is generally assumed that nitric oxide ...
(Date:12/15/2009)... of Spanish and American researchers found the fossil remains of ... they have published, for the first time, the results of ... of the young cetacean, possibly a baleen whale from the ... the partial fossil remains of a whale from the Lower ... formation, but it is the first time that the results ...
(Date:12/15/2009)... Rip currents exact an enormous emotional and economic toll on ... drown in rip currents each year in U.S. waters and ... thousand deaths worldwide. A serious disconnect exists between rip ... confused with rip tides and undertows, and more importantly, most ... escape, from a rip current. , The goal of the ...
Breaking Biology News(10 mins):Septic shock: Nitric oxide beneficial after all 2Story of 4.5 million-year-old whale unveiled in Huelva 2Story of 4.5 million-year-old whale unveiled in Huelva 3Jack LaLanne Celebrated as Fitness Icon at Star Studded Birthday Bash 59465 1Jack LaLanne Celebrated as Fitness Icon at Star Studded Birthday Bash 59465 2Quantel Signs a Distribution Agreement With US based National Biological 14471 1Quantel Signs a Distribution Agreement With US based National Biological 14471 2Global Vision Helps First Priority Reduce Costs in Tough Times 5476 1Global Vision Helps First Priority Reduce Costs in Tough Times 5476 2
... population, and turning research into commercial enterprises, will ... million) investment announced today by the Engineering and ... (TSB) and the Biotechnology and Biological Sciences Research ... two new centres in areas where world-class scientific ...
... ANGELES -- The National Academy of Sciences (NAS) ... Entertainment Exchange," an initiative designed to connect entertainment ... help the creators of television shows, films, video ... work. The Exchange represents the Academy,s first ...
... the latest American Chemical Society (ACS) News Service Weekly PressPac ... & Engineering News .,Please credit the individual journal or the ... ALL CONTENT IS FOR IMMEDIATE RELEASE EXCEPT ARTICLE #5, which ... 2008. , , , ARTICLE #1 FOR IMMEDIATE RELEASE ...
Other Biology News:£20 million to fight virtual crime and treat our ageing population 2£20 million to fight virtual crime and treat our ageing population 3NAS announces initiative to connect entertainment industry with top experts 2NAS announces initiative to connect entertainment industry with top experts 3American Chemical Society's Weekly PressPac -- Nov. 19, 2008 2American Chemical Society's Weekly PressPac -- Nov. 19, 2008 3American Chemical Society's Weekly PressPac -- Nov. 19, 2008 4American Chemical Society's Weekly PressPac -- Nov. 19, 2008 5American Chemical Society's Weekly PressPac -- Nov. 19, 2008 6American Chemical Society's Weekly PressPac -- Nov. 19, 2008 7American Chemical Society's Weekly PressPac -- Nov. 19, 2008 8
... one plate. The new ArraySlide 96 chamber ... x 7mm) individual printing surfaces for multiple ... studies. Unlike other systems, this device utilizes ... of contaminating adhesives. The chamber itself is ...
... System is an automated multiplexing platform that ... detection, pathogen sequence detection and pharmacogenetics applications. ... applied to an open and flexible electronic ... reused until all tests sites have been ...
... siTrio siRNA --- a cocktail of 3 ... of interestis our most popular product. The ... 75% knockdown of your target gene when ... for transfection and confirmation of optimal transfection ...
... offers a large collection of phage ... tissuea, cell lines, and mouse tissues. ... pHD9 vector. The size of cDNA ... from 200bp to 1000bp by gel ...
Biology Products: